Aurinia Pharmaceuticals Inc (AUPH) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Aurinia Pharmaceuticals Inc   (NASDAQ: AUPH)
 

Aurinia Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Aurinia Pharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 2.34 in the second quarter 2026, unsurprisingly, as the Aurinia Pharmaceuticals Inc markets continue to deteriorate, and AUPH's faces growing challenges to bring down its inventories. Aurinia Pharmaceuticals Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 156 days, from 26 days, in the Mar 31 2026 quarter.

Within Healthcare sector 163 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 288, from total ranking in the first quarter 2026 at 1754.

AUPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aurinia Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AUPH Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 1658.9 % 17.84 % -58.03 % - 413.4 %
Y / Y Cost of Sales Growth -7.87 % -24.13 % 58.48 % 35.49 % -20.14 %
Inventory Turnover Ratio (TTM) 2.34 14.12 16.31 13.79 15.26
AUPH's Total Ranking # 288 # 1754 # 1236 # 1183 # 777
Average inventory processing period 156 26 22 26 24
Seq. Inventory Growth 941.79 % 1043.54 % -72.64 % -46.05 % -30.21 %
Seq. Cost of Sales Growth 0.77 % -26.07 % 7.61 % 14.93 % -17.02 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 44
Healthcare Sector # 164
Overall Market # 288

Inventory Turnover Ratio Statistics
High Average Low
42.97 6.53 0.04
(Jun 30 2024)   (Sep 30 2021)



AUPH Company Profile >> Back to AUPH Efficiency Comparisons >> Compare AUPH Inventory Turnover Ratio to its Competitors

Financial Statements
Aurinia Pharmaceuticals Inc 's Inventories $ 45 Millions Visit AUPH's Balance sheet
Aurinia Pharmaceuticals Inc 's Cost of Revenues TTM $ 30 Millions Visit AUPH's Income Statement
What are AUPH's Sales? Visit AUPH's Sales by Segment

Other Inventory Turnover Ratios
Aurinia Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AUPH's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AUPH's Competitors
Inventory Turnover Ratio for AUPH's Suppliers
Inventory Turnover Ratio for AUPH's Customers

You may also want to know
AUPH's Sales Growth Rates AUPH's Pe Price to earnings ratio AUPH's Receivables Turnover Ratio AUPH's Stock Quote
AUPH's Net Income Growth Rates AUPH's Ps Price to Sales ratio AUPH's Sales per Employee AUPH's Asset Turnover Ratio
AUPH's Net Margin AUPH's Pb Price to Book ratio AUPH's Financial Strength Ratios AUPH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Trisalus Life Sciences Inc   1.82 $ 6.508  Millions$ 4  Millions
Halozyme Therapeutics Inc   1.79 $ 292.421  Millions$ 164  Millions
Seastar Medical Holding Corp  1.78 $ 0.126  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.76 $ 38.696  Millions$ 22  Millions
Tenet Healthcare Corp  1.76 $ 605.000  Millions$ 344  Millions
Tenon Medical Inc   1.76 $ 1.763  Millions$ 1  Millions
Iradimed Corporation  1.76 $ 20.839  Millions$ 12  Millions
Utah Medical Products Inc  1.75 $ 14.771  Millions$ 8  Millions
Elutia Inc   1.75 $ 4.337  Millions$ 2  Millions
Axsome Therapeutics Inc   1.73 $ 52.530  Millions$ 30  Millions
Vycor Medical Inc   1.72 $ 0.301  Millions$ 0  Millions
Harvard Bioscience Inc   1.71 $ 37.097  Millions$ 22  Millions
Quanterix Corporation  1.69 $ 87.760  Millions$ 52  Millions
Haemonetics Corporation  1.68 $ 553.577  Millions$ 329  Millions
Conmed Corporation  1.68 $ 606.349  Millions$ 362  Millions
Stryker Corp  1.67 $ 9,049.000  Millions$ 5,405  Millions
Atricure Inc   1.67 $ 134.975  Millions$ 81  Millions
Ceribell Inc   1.66 $ 11.159  Millions$ 7  Millions
The Cooper Companies Inc   1.65 $ 1,443.300  Millions$ 875  Millions
Procept Biorobotics Corporation  1.65 $ 120.119  Millions$ 73  Millions
Sanuwave Health Inc   1.62 $ 10.421  Millions$ 6  Millions
Bio rad Laboratories Inc   1.62 $ 1,245.200  Millions$ 769  Millions
Innovative Eyewear Inc   1.61 $ 2.634  Millions$ 2  Millions
Ultragenyx Pharmaceutical Inc   1.60 $ 87.336  Millions$ 55  Millions
Pfizer Inc  1.60 $ 17,084.000  Millions$ 10,684  Millions
Capsovision Inc   1.60 $ 5.736  Millions$ 4  Millions
Lakeland Industries Inc   1.59 $ 128.669  Millions$ 81  Millions
Integra Lifesciences Holdings Corp  1.59 $ 783.084  Millions$ 492  Millions
Ss Innovations International Inc  1.58 $ 28.689  Millions$ 18  Millions
Rapid Micro Biosystems Inc   1.57 $ 29.477  Millions$ 19  Millions

Date modified: 2026-09-08T16:39:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.